Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade
Trxade Group Inc.
-(MEDS)
XNAS:MEDS
CEO TALKS: The story of Trxade Group (MEDS)
Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu
Trxade (NASDAQ: MEDS) may have been on a dream run of late due to the strong demand for PPE, but the drug
Trxade Group Inc. (MEDS) Q3 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 earnings call dated Oct. 26, 2020 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) delivers another quarter of strong revenue growth
Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales.
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $49 million Trxade Group (NASDAQ: MEDS) operates a web-based purchasing platform that brings together independent
6 promising small-cap stocks that are relatively under the radar
When Amazon (NASDAQ: AMZN) went public in 1997, it had a market of just over $400 million, thereby falling into the small-cap
Trxade launches integrated COVID-19 risk assessment tool for corporate clients
Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such as COVID-19
No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu
A lot is being spoken and written about Amazon (NASDAQ: AMZN), Shopify (NYSE: SHOP) and JD.com (NASDAQ: JD) and their prospects in
Trxade Group Inc. (MEDS) Q2 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q2 2020 earnings call dated July 27, 2020 Corporate Participants: Suren Ajjarapu -- Founder, Chairman and Chief Executive Officer
Trxade (MEDS) stock soars after a big top-line beat
Trxade (NASDAQ: MEDS) on Monday posted second-quarter revenues that more-than-tripled to $6.6 million, primarily driven by higher sales of personal protective equipment
Trxade (MEDS) aims to take on pharmacy chains with an alternate online network
Online pharmaceutical purchases have seen a steady increase in the US over the past decade and the pandemic is now expected to
A visual representation of Trxade Group (MEDS) Q1 2020 earnings
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the